Abstract
The effect of dopamine on thyrotropin (TSH) and prolactin (PRL) levels was studied in 5 normal subjects, 7 women with galactorrhea, 9 acromegalics and 4 patients with primary hypothyroidism. Dopamine infused at the rate of 280 μg/min produced significant decrease in plasma TSH and PRL levels in all four groups, though a lower fall in TSH was noted in acromegalics. A similar reduction in PRL was also noted after 28 μg/min dopamine. Phentolamine infusion (0.5 mg/min) had no effect on PRL response to dopamine. These results indicate that a dopaminergic stimulation led to an inhibition of TSH and PRL secretion. Since the high polarity of dopamine impedes its passage through the blood-brain barrier, its site of action should be outside this barrier, probably in the pituitary.
Similar content being viewed by others
References
Malarkey W.B., Jacobs L.S., Daughaday W.H. Levodopa suppression of prolactin in non puerperal galactorrhea. N. Engl. J. Med. 285: 1160, 1971.
Friesen H.G., Guyda H.J., Hwang P., Tyson J.E. and Barbeau A. Functional evaluation of prolactin secretion: a guide to therapy. J.Clin. Invest. 51: 706, 1972.
Del Pozo E., Friesen H., Burmeister P. Endocrine profile of a specific prolactin inhibitor: Br-Ergocryptine (CB154). Schweiz. Med. Wochenschr. 103: 847, 1973.
Martin J.B., Lal S., Tolis G., Friesen H.G. Inhibition by apomorphine of prolactin secretion in patients with elevated serum prolactin. J. Clin. Endocrinol. Metab. 39: 180, 1974.
Nilsson K.O., Wid L., Hokfelt B. The effect of apomorphine on basal and TRH stimulated release of thyrotropin and prolactin in man. Acta Endocrinol. (Kbh) 80: 220, 1975.
Massara F., Camanni F., Belforte L., Molinatti G.M. Dopamine-induced inhibition of PRL and GH secretion in acromegaly. Lancet 1: 485, 1976.
Leblanc H., Lachelin G.C.L., Abu-Fadil S., Yen S.S.C. Effects of dopamine infusion on pituitary hormone secretion in humans. J. Clin. Endocrinol. Metab. 43: 668, 1976.
Camanni F., Massara F., Belforte L., Rosatello A., Molinatti G.M. Effect of dopamine on plasma growth hormone and prolactin levels in normal acromegalic subjects. J. Clin. Endocrinol. Metab. 44: 465, 1977.
Meites J., Lu K.H., Wuttke W., Welsch C.W., Nagasawa H., Quadri S.K. Recent studies on functions and control of Prolactin secretion in rats. Recent Prog. Horm. Res. 28: 471, 1972.
Mac Leod R.M. Influence of norepinephrine and catecholamine depleting agents on the synthesis and release of prolactin and growth hormone. Endocrinology 85: 916, 1969.
Birge C.A., Jacobs L.S., Hammer C.T., Daughaday W.H. Catecholamine inhibition of prolactin secretion by isolated rat adenohypophysis. Endocrinology 86: 120, 1970.
Takahara J., Arimura A., Schally A.V. Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel. Endocrinology 96: 462, 1974.
Eddy R.L., Jones A.L., Chakmakjian H., Silverthorne M.C. Effect of levodopa on human hypophyseal trophic hormone release. J. Clin. Endocrinol. Metab. 33: 709, 1971.
Spaulding S.W., Burrow G.N., Donabedian R., Van Woert M. L-Dopa supression of thyrotropin-releasing hormone response in man. J. Clin. Endocrinol Metab. 35: 182, 1972.
Miyai K., Onishi T., Hosokawa M., Ishibashi K., Kumahara Y. Inhibition of thyrotropin and prolactin secretion in primary hypothyroidism by 2-Br-alpha-ergocriptine. J. Clin. Endocrinol. Metab. 39: 391, 1974.
Refetoff S., Fang V.S., Rapoport B., Friesen H.G. Interrelationships in the regulation of TSH and PRL secretion in man: effects of L-Dopa, TRH and thyroid hormone in various conditions. J. Clin. Endocrinol. Metab. 38: 450, 1974.
Tsukui T., Kanno Y., Koizumi Y., Hashizume K., Onaya T., Yamada T. Species specificity in the TSH response to the administration of L-Dopa. Proc. Soc. Exp. Biol. Med. 145: 346, 1974.
Besses G.S., Burrow G.N., Spaulding S.W., Donabedian R.K. Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. J. Clin. Endocrinol. Metab. 41: 985, 1975.
Chen H.J., Meites J. Effects of biogenic amines and TRH on release of prolactin and TSH in the rat. Endocrinology 96: 10, 1975.
Collu R., Jequier J.C., Leboeuf G., Letarte J., Ducharme J.R. Endocrine effects of pimozide, a specific dopaminergic blocker. J. Clin. Endocrinol. Metab. 41: 981, 1975.
Minozzi M., Faggiano M., Lombardi G., Carella C., Criscuolo T., Scapagnini V. Effect of L-Dopa on plasma TSH levels in primary hypothyroidism. Neuroendocrinology 17: 147, 1975.
Ferrari C., Beck-Pecoz P., Paracchi A., Rondena M., Ambrosi B., Travaglini P., Spada A., Faglia G. Controllo monoaminergico delia secrezione della prolattina e dell’ormone tireotropo. Atti XVI Congr. Soc. Italiana di Endocrinologia, Bari, 18–21 maggio 1976, Serono Symposia, p. 102.
Massara F., Belforte L., Vergano V., Camanni F., Molinatti G.M. Inibizione della secrezione di prolattina e Tireotropina indotta dalla dopamina nell’uomo. Atti XVI Congr. Soc. Italiana di Endocrinologia, Bari, 18–21 maggio 1976, Serono Symposia, 42, 1976.
Dobbing J. The blood-brain barrier. Physiol. Rev. 41: 130, 1961.
Brown G.M., Seeman P., Lee T. Dopamine neuroleptic receptors in basal hypothalamus and pituitary. Endocrinology 99: 1407, 1976.
Schally A.V., Arimura A., Kastin A.J. Hypothalamic regulatory hormones. Science 179: 341, 1973.
Van der Gugten A.A., Sahuleka P.C., Van Galen G.H., Kwa H.G. Prolactin inhibition test with L-Dopa: decrease and restoration of plasma prolactin levels in the rat by a peripheral process. Endocrinol. 68: 369, 1976.
Reichlin S. Regulation of the hypophysiotropic secretions of the brain. Arch. Intern. Med. 135: 1350, 1975.
Mac Leod R.M., Fontham E.H., Lehmeyer J.E. Prolactin and growth hormone production as influenced by catecholamines and agents that affects brain catecholamines. Neuroendocrinology 6: 283, 1970.
Shaar C.J., Clemens J.A. The rôle of catecholamines in the release of anterior pituitary prolactin in vitro. Endocrinology 95: 1202, 1974.
Goodman L.S., Golman A. The pharmacological basis of therapeutics. The Mac Millan Company, 559, 1965.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Massara, F., Camanni, F., Vergano, V. et al. Inhibition of thyrotropin and prolactin secretion by dopamine in man. J Endocrinol Invest 1, 25–30 (1978). https://doi.org/10.1007/BF03346767
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346767